LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
BT-20 Seliciclib
10.0
uM
LJP5
 3
J01
 72
hr
 1097 1616 3769 0.4287 0.1941
BT-20 Ruxolitinib
10.0
uM
LJP5
 1
O13
 72
hr
 1097 3124 3769 0.8288 0.7584
BT-20 Ruxolitinib
10.0
uM
LJP5
 2
O13
 72
hr
 1097 3125 3769 0.8290 0.7588
BT-20 Ruxolitinib
10.0
uM
LJP5
 3
O13
 72
hr
 1097 3195 3769 0.8476 0.7850
BT-20 XL147
10.0
uM
LJP5
 1
G07
 72
hr
 1097 1523 3769 0.4040 0.1593
BT-20 XL147
10.0
uM
LJP5
 2
G07
 72
hr
 1097 1702 3769 0.4515 0.2263
BT-20 XL147
10.0
uM
LJP5
 3
G07
 72
hr
 1097 1517 3769 0.4024 0.1571
BT-20 Saracatinib
10.0
uM
LJP6
 1
D07
 72
hr
 1097 1699 3769 0.4507 0.2252
BT-20 Saracatinib
10.0
uM
LJP6
 2
D07
 72
hr
 1097 1591 3769 0.4221 0.1848
BT-20 Saracatinib
10.0
uM
LJP6
 3
D07
 72
hr
 1097 1734 3769 0.4600 0.2383
BT-20 Selumetinib
10.0
uM
LJP6
 1
M07
 72
hr
 1097 3540 3769 0.9391 0.9141
BT-20 Selumetinib
10.0
uM
LJP6
 2
M07
 72
hr
 1097 3277 3769 0.8693 0.8157
BT-20 Selumetinib
10.0
uM
LJP6
 3
M07
 72
hr
 1097 3090 3769 0.8197 0.7457
BT-20 Sirolimus
10.0
uM
LJP6
 1
L13
 72
hr
 1097 2348 3769 0.6229 0.4680
BT-20 Sirolimus
10.0
uM
LJP6
 2
L13
 72
hr
 1097 2319 3769 0.6152 0.4572
BT-20 Sirolimus
10.0
uM
LJP6
 3
L13
 72
hr
 1097 2339 3769 0.6205 0.4647
BT-20 Sorafenib
10.0
uM
LJP6
 1
B07
 72
hr
 1097 1236 3769 0.3279 0.0519
BT-20 Sorafenib
10.0
uM
LJP6
 2
B07
 72
hr
 1097 1510 3769 0.4006 0.1545
BT-20 Sorafenib
10.0
uM
LJP6
 3
B07
 72
hr
 1097 1238 3769 0.3284 0.0527
BT-20 SU11274
10.0
uM
LJP5
 1
J07
 72
hr
 1097 1329 3769 0.3526 0.0867
BT-20 SU11274
10.0
uM
LJP5
 2
J07
 72
hr
 1097 1206 3769 0.3199 0.0407
BT-20 SU11274
10.0
uM
LJP5
 3
J07
 72
hr
 1097 1218 3769 0.3231 0.0452
BT-20 Fedratinib
10.0
uM
LJP5
 1
L01
 72
hr
 1097 752 3769 0.1995 -0.1292
BT-20 Fedratinib
10.0
uM
LJP5
 2
L01
 72
hr
 1097 815 3769 0.2162 -0.1056
BT-20 Fedratinib
10.0
uM
LJP5
 3
L01
 72
hr
 1097 702 3769 0.1862 -0.1479